@ARTICLE{
author={van Dussen Laura,Zimran An,Akkerman EM,Aerts JMFG,Petakov Milan S,Elstein Deborah,Rosenbaum H,Aviezer David,Brill-Almon Einat,Chertkoff Raul,Maas M,Hollak CEM},
year={2013},
title={Taliglucerase alfa leads to favorable bone marrow responses in patients with type I Gaucher disease},
journal={BLOOD CELLS MOLECULES AND DISEASES},
volume={50},
number={3},
pages={206-211},
document_type={Article},
} 

@ARTICLE{
author={Zimran Ari,Brill-Almon Einat,Chertkoff Raul,Petakov Milan S,Blanco-Favela Francisco,Munoz Eduardo Terreros,Solorio Meza Sergio Eduardo,Amato Dominick J,Duran Gloria,Giona Florina,Heitner Rene,Rosenbaum Hanna,Giraldo Pilar,Mehta Atul,Park Glen,Phillips Mici,Elstein Deborah,Altarescu Gheona,Szleifer Mali,Hashmueli Sharon,Aviezer David},
year={2012},
title={Pivotal trial with plant cell-expressed recombinant glucocerebrosidase, taliglucerase alfa, a novel enzyme replacement therapy for Gaucher disease <font color='#0066ff'><strong>(Erratum - errors in Affiliations - vol 118, pg 5767, 2011)</strong></font>},
journal={BLOOD},
volume={119},
number={19},
pages={4577-4577},
document_type={Correction},
} 

@ARTICLE{
author={van Dussen Laura,Hollak Carla EM,Zimran Ari,Petakov Milan S,Rosenbaum Hanna,Aviezer David,Brill-Almon Einat,Chertkoff Raul,Maas Mario},
year={2012},
title={Long Term Bone Marrow Responses, as Measured by Quantitative Chemical Shift Imaging (QCSI) MRI, Following Treatment With Taliglucerase Alfa in Patients with Type 1 Gaucher Disease},
journal={MOLECULAR GENETICS AND METABOLISM},
volume={105},
number={2},
pages={S62-S63},
document_type={Meeting Abstract},
}